Processa Pharmaceuticals
PCSA
NASDAQ
IPO2013
about PCSA
Processa Pharmaceuticals is a clinical-stage biopharmaceutical company that develops "Next Generation Chemotherapy" by re-engineering FDA-approved cancer drugs to improve their safety and effectiveness.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.35 | $8.88 | $3.28 | $272.35K | 39.59M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.07 | n/a | n/a | 0% | 0% | 0% |